SMAD2 and gastric cancer: In gastric cancer (GC), evidence presents that MSCs secreted TGF-β1 promotes fatty acid oxidation (FAO) to support stemness features and drug resistance, which is mediated by activating SMAD2 and SMAD3 and promoting lncRNA MACC1AS1 expression (He et al., 2019).